Top Markets
Coin of the day
Aequus Pharmaceuticals Inc. Aequus Pharmaceuticals Inc.

Aequus Pharmaceuticals Inc.

AQS
Rank in Stocks #39473
Aequus Pharmaceuticals Inc. is a specialized Canadian pharmaceutical company... Aequus Pharmaceuticals Inc. is a specialized Canadian pharmaceutical company dedicated to advancing and commercializing therapeutic solutions. Its core operations span critical areas such as neurology, ophthalmology, and transplantation. The company currently markets a range of products, including Vistitan, an ophthalmic treatment designed to alleviate elevated intraocular pressure in individuals suffering from open-angle glaucoma or ocular hypertension. Another key offering is Tacrolimus IR, an immunosuppressant vital for both preventing and treating acute rejection in organ transplant recipients. Aequus also provides its Evolve line of dry eye products, which target various symptoms associated with dry eye disease and blepharitis, such as discomfort, stinging, burning, and dryness, alongside a preservative-free ophthalmic option. In its development pipeline, Aequus is progressing several innovative candidates. These include Topiramate XR and Oxcarbazepine XR, extended-release oral tablets aimed at epilepsy treatment; AQS1303, a transdermal formulation of pyridoxine/doxylamine developed to combat nausea and vomiting during pregnancy; and AQS1304, a cannabinoid-based therapeutic under investigation for neurological disorders. To support its market reach and innovation, Aequus has forged strategic alliances. These include an agreement with Sandoz Canada, Inc. for the promotion of Vistitan; a partnership with Supernus Pharmaceuticals, Inc. for the marketing of its extended-release anti-epileptic drugs; and a collaboration with Medicom Healthcare Ltd. centered on preservative-free ophthalmic treatments. Established in 2013, Aequus Pharmaceuticals Inc. maintains its corporate headquarters in Vancouver, Canada.
Share Price
$0.00359455
Last synced: 2025-05-20
Market Cap
$476.76K
Change (1 day)
0.44%
Change (1 year)
0.00%
Country
CA
Trade Aequus Pharmaceuticals Inc. (AQS)

Category

Stock price history for Aequus Pharmaceuticals Inc. (AQS)
Highest end of day price: $0.00 on 2025-05-01

Lowest end of day price: $0.55 on 2015-03-01
Stock price history of Aequus Pharmaceuticals Inc. from 2015 to 2026
Annual Stock Price Performance
Year Performance
2025 -2.36%
2024 -82.41%
2023 -5.81%
2022 -74.31%
2021 7.28%
2020 -22.02%
2019 -13.02%
2018 -32.54%
2017 -8.75%
2016 -57.19%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$163.51 26.50%
DE
$36.61 23.93%
JP
$228.25 40.71%
CH
$21.22 13.35%
IN